Table of contents
- Executive summary report (551KB PDF)
- Main report (3.8MB PDF)
- Preliminary material
- Title page and verso
- Letters of transmittal
- Contents
- Executive Summary
- Sections
- Introduction
- Background
- Dapsone
- Sites of cancer of a priori interest
- Report structure
- Aim of the study
- Data collection, collation and analysis
- Identification of the study cohort
- Identification of servicemen who took dapsone or had malaria
- Identification of servicemen with cancer
- Determination of the population at risk
- Potential risk factors
- Analysis of cancer incidence
- Cancer incidence in different groups
- Characteristics of the study population
- Dapsone-exposed Vietnam veterans compared with other Vietnam veterans
- Trends in cancer incidence with total dapsone dose
- Vietnam veterans with malaria compared with other veterans
- Cancer incidence among Vietnam veterans compared with non-veterans
- Dapsone-exposed Vietnam veterans compared with non-veterans
- Vietnam conflict era servicemen compared with other Australian males
- Trends in cancer incidence with latency period
- Cancer incidence in different groups)
- All cancers
- Hodgkin's disease and non-Hodgkin's lymphoma
- Leukaemia
- Soft tissue and other sarcomas
- Cancers of the mouth and respiratory system
- Cancers of the digestive system
- Skin melanoma
- Cancers of other organs
- Conclusion
- Conclusion
- Introduction
- End matter
- Appendixes
- Appendix A: Protocol for an epidemiological study of cancer in servicemen of the Vietnam era particularly in relation to the use of dapsone
- Appendix B: Matching of service and cancer registration records
- Appendix C: Statistical information
- Appendix D: Membership of the Scientific Advisory Committee
- Appendix E: Project staff
- Glossary
- References
- Appendixes